Unlocking the Therapeutic Potential of Ellagitannins: A Comprehensive Review of Key Representatives
Molecules · 07.11.2025 · 30 (22) · 4328
DOI: 10.3390/molecules30224328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 07.11.2025. Verfasst von Rositsa Mihaylova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Hydrolyzable Tannins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria.
Abstract (Originalsprache)
The present review offers a comprehensive synthesis of the structural diversity, natural occurrence, and therapeutic promise of key ellagitannins (punicalagin, sanguiin H-6, corilagin, geraniin, oenothein B, chebulagic, and chebulinic acids) within the hydrolyzable ellagitannin pool. Distributed in medicinal and dietary plants long used in traditional medicine, ellagitannin-rich species serve as sources of both complex polyphenolic scaffolds and their bioactive metabolites, urolithins, which mediate many of their health-promoting effects. Special emphasis is placed on the multifaceted mechanisms that contribute to their potent antioxidant, anti-inflammatory, antimicrobial, and anticancer effects, extending to both non-communicable and communicable diseases. Despite their broad therapeutic spectrum, clinical translation is limited by challenges such as poor bioavailability, host-gut microbiota variability, and a lack of robust in vivo evidence. The review highlights future directions aimed at unlocking ellagitannins’ potential, including microbiota-targeted strategies for urolithin production, the design of stable prodrugs and analogs, and innovative delivery platforms. By integrating phytochemical, mechanistic and translational insights, this article positions ellagitannins as promising candidates for the development of novel polyphenol-based interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
ORCID-Profile: Rositsa Mihaylova, Viktoria Elincheva, Georgi Momekov, Rumyana Simeonova
Förderung
- European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria
Zitieren
APA
Mihaylova, R., Elincheva, V., Momekov, G., & Simeonova, R. (2025). Unlocking the Therapeutic Potential of Ellagitannins: A Comprehensive Review of Key Representatives. Molecules, 30(22), 4328. https://doi.org/10.3390/molecules30224328
Vancouver
Mihaylova R, Elincheva V, Momekov G, Simeonova R. Unlocking the Therapeutic Potential of Ellagitannins: A Comprehensive Review of Key Representatives. Molecules. 2025;30(22):4328. doi:10.3390/molecules30224328
BibTeX
@article{Mihaylova2025,
author = {Mihaylova, Rositsa and Elincheva, Viktoria and Momekov, Georgi and Simeonova, Rumyana},
title = {Unlocking the Therapeutic Potential of Ellagitannins: A Comprehensive Review of Key Representatives},
journal = {Molecules},
year = {2025},
volume = {30},
number = {22},
pages = {4328},
doi = {10.3390/molecules30224328}
}
EUVIMED